| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 57 | 2023 | 514 | 9.940 |
Why?
|
| Breast Neoplasms | 40 | 2022 | 1536 | 4.840 |
Why?
|
| Inflammation | 34 | 2022 | 1030 | 3.940 |
Why?
|
| Prostatic Neoplasms | 20 | 2022 | 778 | 3.280 |
Why?
|
| Feeding Behavior | 19 | 2022 | 224 | 2.860 |
Why?
|
| Postmenopause | 18 | 2021 | 93 | 2.560 |
Why?
|
| Estrogens | 4 | 2018 | 173 | 1.740 |
Why?
|
| Risk Factors | 56 | 2022 | 5731 | 1.700 |
Why?
|
| Pancreatic Neoplasms | 5 | 2019 | 332 | 1.690 |
Why?
|
| Glycation End Products, Advanced | 3 | 2023 | 125 | 1.600 |
Why?
|
| Colorectal Neoplasms | 12 | 2020 | 561 | 1.500 |
Why?
|
| Middle Aged | 96 | 2021 | 21147 | 1.400 |
Why?
|
| Aged | 79 | 2023 | 14862 | 1.380 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 10 | 2017 | 38 | 1.290 |
Why?
|
| Neoplasms | 10 | 2022 | 1667 | 1.280 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 940 | 1.260 |
Why?
|
| Female | 103 | 2022 | 38074 | 1.180 |
Why?
|
| Humans | 134 | 2023 | 68618 | 1.170 |
Why?
|
| Women's Health | 10 | 2022 | 148 | 1.150 |
Why?
|
| Diet, Mediterranean | 6 | 2018 | 12 | 1.130 |
Why?
|
| Colonic Neoplasms | 6 | 2020 | 299 | 1.110 |
Why?
|
| Neoplasm Invasiveness | 5 | 2019 | 369 | 1.090 |
Why?
|
| Polymorphism, Genetic | 10 | 2016 | 301 | 1.080 |
Why?
|
| Life Style | 8 | 2019 | 338 | 1.070 |
Why?
|
| Meat | 7 | 2022 | 34 | 1.060 |
Why?
|
| Proportional Hazards Models | 15 | 2022 | 792 | 1.040 |
Why?
|
| Risk Assessment | 11 | 2021 | 2007 | 1.020 |
Why?
|
| Exercise | 11 | 2022 | 658 | 1.010 |
Why?
|
| Surveys and Questionnaires | 31 | 2020 | 2800 | 0.980 |
Why?
|
| Energy Intake | 12 | 2022 | 123 | 0.940 |
Why?
|
| Body Mass Index | 21 | 2022 | 867 | 0.920 |
Why?
|
| Follow-Up Studies | 22 | 2022 | 3259 | 0.890 |
Why?
|
| North Carolina | 13 | 2022 | 224 | 0.880 |
Why?
|
| Case-Control Studies | 33 | 2022 | 1553 | 0.870 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2018 | 627 | 0.860 |
Why?
|
| Odds Ratio | 21 | 2018 | 880 | 0.840 |
Why?
|
| Brassica | 3 | 2022 | 13 | 0.840 |
Why?
|
| Louisiana | 12 | 2022 | 37 | 0.800 |
Why?
|
| Adenocarcinoma | 5 | 2017 | 475 | 0.800 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2018 | 7 | 0.780 |
Why?
|
| Male | 70 | 2022 | 37321 | 0.770 |
Why?
|
| Glutathione Transferase | 4 | 2014 | 166 | 0.760 |
Why?
|
| Adult | 60 | 2023 | 21403 | 0.750 |
Why?
|
| Prospective Studies | 17 | 2022 | 3705 | 0.740 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2018 | 786 | 0.740 |
Why?
|
| Heterocyclic Compounds | 3 | 2014 | 24 | 0.730 |
Why?
|
| C-Reactive Protein | 9 | 2016 | 180 | 0.730 |
Why?
|
| Early Detection of Cancer | 4 | 2020 | 454 | 0.730 |
Why?
|
| Cooking | 5 | 2017 | 19 | 0.710 |
Why?
|
| Platelet Transfusion | 1 | 2020 | 21 | 0.710 |
Why?
|
| Health Behavior | 5 | 2016 | 458 | 0.700 |
Why?
|
| Lysine | 1 | 2020 | 96 | 0.690 |
Why?
|
| DNA Repair | 3 | 2016 | 127 | 0.680 |
Why?
|
| Obesity | 9 | 2022 | 1076 | 0.680 |
Why?
|
| Dietary Carbohydrates | 4 | 2017 | 27 | 0.660 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 179 | 0.650 |
Why?
|
| Blood Platelets | 1 | 2020 | 284 | 0.640 |
Why?
|
| Vitamin D | 4 | 2019 | 516 | 0.640 |
Why?
|
| Isothiocyanates | 2 | 2009 | 10 | 0.620 |
Why?
|
| Calcium, Dietary | 1 | 2018 | 35 | 0.620 |
Why?
|
| Risk | 9 | 2018 | 563 | 0.620 |
Why?
|
| Milk | 1 | 2018 | 43 | 0.620 |
Why?
|
| Overweight | 5 | 2019 | 186 | 0.610 |
Why?
|
| Cancer Survivors | 2 | 2018 | 146 | 0.600 |
Why?
|
| Health Promotion | 4 | 2016 | 407 | 0.600 |
Why?
|
| Magnesium | 1 | 2018 | 110 | 0.600 |
Why?
|
| Nutrition Assessment | 10 | 2018 | 43 | 0.590 |
Why?
|
| Amines | 2 | 2009 | 98 | 0.580 |
Why?
|
| Contraceptives, Oral | 1 | 2016 | 28 | 0.560 |
Why?
|
| Incidence | 16 | 2020 | 1603 | 0.550 |
Why?
|
| Chronic Disease | 3 | 2019 | 1330 | 0.540 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 69 | 0.540 |
Why?
|
| Population Surveillance | 4 | 2018 | 285 | 0.530 |
Why?
|
| Progestins | 1 | 2015 | 19 | 0.530 |
Why?
|
| Cause of Death | 5 | 2022 | 241 | 0.530 |
Why?
|
| Phylogeny | 1 | 2015 | 197 | 0.470 |
Why?
|
| Medicaid | 1 | 2016 | 302 | 0.470 |
Why?
|
| United States | 22 | 2022 | 7367 | 0.470 |
Why?
|
| Calcium | 1 | 2018 | 929 | 0.470 |
Why?
|
| Diet Surveys | 6 | 2017 | 24 | 0.460 |
Why?
|
| New York | 15 | 2017 | 223 | 0.460 |
Why?
|
| Nutritional Status | 4 | 2015 | 112 | 0.440 |
Why?
|
| Cross-Sectional Studies | 11 | 2022 | 2279 | 0.440 |
Why?
|
| Flavonoids | 5 | 2015 | 109 | 0.430 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 446 | 0.430 |
Why?
|
| Oxidative Stress | 5 | 2021 | 718 | 0.430 |
Why?
|
| Rectal Neoplasms | 3 | 2020 | 75 | 0.420 |
Why?
|
| Nutrition Surveys | 8 | 2022 | 208 | 0.410 |
Why?
|
| Environmental Exposure | 5 | 2016 | 269 | 0.400 |
Why?
|
| Community-Based Participatory Research | 2 | 2012 | 133 | 0.390 |
Why?
|
| Aged, 80 and over | 22 | 2018 | 4848 | 0.390 |
Why?
|
| Meditation | 1 | 2011 | 33 | 0.380 |
Why?
|
| Quality of Life | 2 | 2016 | 1515 | 0.370 |
Why?
|
| Biomarkers | 10 | 2019 | 1593 | 0.370 |
Why?
|
| Fruit | 5 | 2022 | 86 | 0.370 |
Why?
|
| Vegetables | 5 | 2022 | 76 | 0.370 |
Why?
|
| Antioxidants | 4 | 2022 | 304 | 0.360 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2015 | 41 | 0.350 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 700 | 0.350 |
Why?
|
| Siblings | 2 | 2021 | 34 | 0.350 |
Why?
|
| Prognosis | 6 | 2021 | 2093 | 0.340 |
Why?
|
| Community Participation | 1 | 2009 | 42 | 0.320 |
Why?
|
| Folic Acid | 2 | 2013 | 123 | 0.320 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 334 | 0.320 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2008 | 2 | 0.320 |
Why?
|
| Prostate-Specific Antigen | 6 | 2016 | 138 | 0.320 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2008 | 2 | 0.320 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2008 | 3 | 0.320 |
Why?
|
| Language | 1 | 2009 | 120 | 0.310 |
Why?
|
| Dietary Supplements | 6 | 2016 | 332 | 0.300 |
Why?
|
| Rural Population | 2 | 2022 | 398 | 0.300 |
Why?
|
| Body Weight | 3 | 2019 | 554 | 0.300 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 1046 | 0.300 |
Why?
|
| Young Adult | 20 | 2020 | 5717 | 0.300 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2007 | 4 | 0.290 |
Why?
|
| Insulin Resistance | 4 | 2018 | 241 | 0.290 |
Why?
|
| Seafood | 3 | 2017 | 17 | 0.290 |
Why?
|
| Genotype | 7 | 2016 | 786 | 0.290 |
Why?
|
| Logistic Models | 12 | 2017 | 1420 | 0.280 |
Why?
|
| Age Factors | 4 | 2016 | 1864 | 0.280 |
Why?
|
| Esophageal Neoplasms | 2 | 2017 | 150 | 0.280 |
Why?
|
| Carcinoma | 1 | 2008 | 215 | 0.280 |
Why?
|
| Body Composition | 1 | 2007 | 119 | 0.280 |
Why?
|
| Communication | 1 | 2009 | 329 | 0.270 |
Why?
|
| South Carolina | 10 | 2022 | 2752 | 0.270 |
Why?
|
| Barrett Esophagus | 2 | 2017 | 57 | 0.270 |
Why?
|
| Vehicle Emissions | 2 | 2016 | 11 | 0.260 |
Why?
|
| Smoking | 5 | 2016 | 1452 | 0.260 |
Why?
|
| Carotenoids | 2 | 2016 | 45 | 0.260 |
Why?
|
| Cohort Studies | 9 | 2018 | 2358 | 0.260 |
Why?
|
| Body Size | 2 | 2016 | 39 | 0.260 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 378 | 0.260 |
Why?
|
| Tocopherols | 2 | 2015 | 7 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2009 | 310 | 0.260 |
Why?
|
| Air Pollution, Indoor | 2 | 2016 | 26 | 0.250 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 425 | 0.250 |
Why?
|
| Socioeconomic Factors | 10 | 2022 | 955 | 0.250 |
Why?
|
| DNA Methylation | 2 | 2017 | 193 | 0.250 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 212 | 0.250 |
Why?
|
| Adenomatous Polyps | 2 | 2015 | 18 | 0.250 |
Why?
|
| Health | 2 | 2015 | 26 | 0.250 |
Why?
|
| Period Circadian Proteins | 2 | 2014 | 16 | 0.240 |
Why?
|
| Nutrition Policy | 2 | 2015 | 44 | 0.240 |
Why?
|
| Adipose Tissue | 2 | 2016 | 221 | 0.240 |
Why?
|
| Environmental Pollutants | 2 | 2016 | 180 | 0.230 |
Why?
|
| DNA Adducts | 3 | 2015 | 7 | 0.230 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 191 | 0.220 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 805 | 0.220 |
Why?
|
| Fabaceae | 1 | 2022 | 12 | 0.220 |
Why?
|
| Intestines | 2 | 2015 | 114 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2019 | 222 | 0.220 |
Why?
|
| Animals | 9 | 2022 | 20881 | 0.210 |
Why?
|
| Poverty | 2 | 2016 | 219 | 0.210 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 244 | 0.200 |
Why?
|
| Survival Analysis | 3 | 2019 | 714 | 0.200 |
Why?
|
| Receptors, Estrogen | 3 | 2018 | 142 | 0.200 |
Why?
|
| Survival Rate | 4 | 2017 | 1056 | 0.200 |
Why?
|
| Blood Glucose | 4 | 2018 | 631 | 0.200 |
Why?
|
| Plant Proteins | 1 | 2022 | 48 | 0.200 |
Why?
|
| Lignans | 2 | 2015 | 10 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1085 | 0.190 |
Why?
|
| Cattle | 3 | 2022 | 475 | 0.190 |
Why?
|
| Prostate | 2 | 2019 | 116 | 0.190 |
Why?
|
| Comorbidity | 3 | 2022 | 1426 | 0.190 |
Why?
|
| Motor Activity | 4 | 2015 | 621 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2020 | 1342 | 0.180 |
Why?
|
| Health Status | 2 | 2013 | 429 | 0.180 |
Why?
|
| Micronutrients | 2 | 2018 | 31 | 0.180 |
Why?
|
| Triglycerides | 2 | 2018 | 184 | 0.180 |
Why?
|
| Cytokines | 2 | 2017 | 866 | 0.180 |
Why?
|
| Linear Models | 4 | 2015 | 521 | 0.180 |
Why?
|
| Food Preferences | 2 | 2017 | 46 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 163 | 0.180 |
Why?
|
| Platelet Count | 1 | 2020 | 100 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2022 | 252 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2022 | 502 | 0.170 |
Why?
|
| Cholesterol | 2 | 2018 | 331 | 0.170 |
Why?
|
| Vitamins | 2 | 2017 | 134 | 0.170 |
Why?
|
| Breakfast | 1 | 2019 | 2 | 0.170 |
Why?
|
| Urban Population | 1 | 2020 | 255 | 0.170 |
Why?
|
| Community Networks | 2 | 2012 | 96 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2022 | 7277 | 0.160 |
Why?
|
| Acidosis | 1 | 2018 | 31 | 0.160 |
Why?
|
| Calcitriol | 1 | 2019 | 106 | 0.160 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2016 | 127 | 0.160 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2018 | 16 | 0.160 |
Why?
|
| ABO Blood-Group System | 1 | 2018 | 15 | 0.160 |
Why?
|
| Stress, Psychological | 3 | 2014 | 824 | 0.160 |
Why?
|
| Teaching Materials | 1 | 2018 | 16 | 0.160 |
Why?
|
| Coffee | 2 | 2022 | 18 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 267 | 0.150 |
Why?
|
| Eating | 2 | 2009 | 119 | 0.150 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 18 | 0.150 |
Why?
|
| Diet, Western | 1 | 2017 | 17 | 0.150 |
Why?
|
| Starch | 1 | 2017 | 18 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2017 | 37 | 0.150 |
Why?
|
| Dietary Sugars | 1 | 2017 | 7 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 10 | 0.150 |
Why?
|
| Health Literacy | 1 | 2018 | 63 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 581 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 110 | 0.150 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 64 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 99 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2017 | 20 | 0.140 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2017 | 37 | 0.140 |
Why?
|
| Frail Elderly | 1 | 2017 | 31 | 0.140 |
Why?
|
| Interleukins | 2 | 2016 | 79 | 0.140 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2016 | 14 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 206 | 0.140 |
Why?
|
| Hip Fractures | 1 | 2017 | 26 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 157 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 240 | 0.140 |
Why?
|
| Registries | 2 | 2018 | 733 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 626 | 0.140 |
Why?
|
| Levonorgestrel | 1 | 2015 | 6 | 0.130 |
Why?
|
| Contraceptive Agents, Female | 1 | 2015 | 16 | 0.130 |
Why?
|
| Dinoprost | 1 | 2015 | 27 | 0.130 |
Why?
|
| Educational Status | 1 | 2016 | 273 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 12 | 0.130 |
Why?
|
| Aging | 1 | 2022 | 911 | 0.130 |
Why?
|
| Thioredoxins | 1 | 2015 | 26 | 0.130 |
Why?
|
| Veterans Health | 1 | 2016 | 62 | 0.130 |
Why?
|
| Dementia | 1 | 2017 | 158 | 0.130 |
Why?
|
| Forecasting | 1 | 2016 | 277 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2016 | 94 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2017 | 318 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 84 | 0.120 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2014 | 24 | 0.120 |
Why?
|
| Prevalence | 4 | 2016 | 1619 | 0.120 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2014 | 21 | 0.120 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 12 | 0.120 |
Why?
|
| Insulin | 1 | 2018 | 619 | 0.120 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2014 | 13 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 49 | 0.120 |
Why?
|
| Eczema | 1 | 2014 | 10 | 0.120 |
Why?
|
| Disease Progression | 4 | 2022 | 1038 | 0.120 |
Why?
|
| Air Pollutants | 1 | 2015 | 75 | 0.120 |
Why?
|
| Police | 1 | 2014 | 34 | 0.120 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2014 | 58 | 0.120 |
Why?
|
| Benzopyrenes | 1 | 2014 | 1 | 0.120 |
Why?
|
| Demography | 1 | 2015 | 279 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2018 | 219 | 0.120 |
Why?
|
| Globulins | 1 | 2014 | 2 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 163 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2016 | 402 | 0.120 |
Why?
|
| Health Status Disparities | 2 | 2020 | 326 | 0.120 |
Why?
|
| Work Schedule Tolerance | 1 | 2014 | 18 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 176 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.120 |
Why?
|
| Carcinogens | 1 | 2014 | 86 | 0.110 |
Why?
|
| Albumins | 1 | 2014 | 72 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 931 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 81 | 0.110 |
Why?
|
| Mammography | 1 | 2016 | 310 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 615 | 0.110 |
Why?
|
| Testosterone | 1 | 2014 | 96 | 0.110 |
Why?
|
| Adenoma | 1 | 2014 | 132 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 218 | 0.110 |
Why?
|
| Mental Recall | 2 | 2013 | 72 | 0.110 |
Why?
|
| Centralized Hospital Services | 1 | 2012 | 3 | 0.110 |
Why?
|
| Estradiol | 1 | 2014 | 176 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 561 | 0.110 |
Why?
|
| Medication Systems, Hospital | 1 | 2012 | 19 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 231 | 0.100 |
Why?
|
| Fish Oils | 1 | 2012 | 21 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 123 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2550 | 0.100 |
Why?
|
| Body Image | 1 | 2013 | 100 | 0.100 |
Why?
|
| Adolescent | 8 | 2017 | 8912 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2012 | 41 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2014 | 204 | 0.100 |
Why?
|
| Caffeine | 1 | 2012 | 81 | 0.100 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 14 | 0.100 |
Why?
|
| Workflow | 1 | 2012 | 100 | 0.100 |
Why?
|
| Diet Records | 3 | 2017 | 14 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1173 | 0.090 |
Why?
|
| Child | 2 | 2020 | 6405 | 0.090 |
Why?
|
| Universities | 1 | 2012 | 191 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 207 | 0.090 |
Why?
|
| Asthma | 1 | 2014 | 345 | 0.090 |
Why?
|
| Premenopause | 2 | 2007 | 57 | 0.090 |
Why?
|
| Attention | 1 | 2012 | 225 | 0.090 |
Why?
|
| Electronic Mail | 1 | 2010 | 29 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 565 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 235 | 0.090 |
Why?
|
| Sex Factors | 2 | 2015 | 1266 | 0.090 |
Why?
|
| Intention | 1 | 2010 | 80 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2009 | 22 | 0.080 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2009 | 1 | 0.080 |
Why?
|
| Rhinitis | 1 | 2014 | 383 | 0.080 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 47 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 52 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2009 | 62 | 0.080 |
Why?
|
| Canada | 1 | 2009 | 267 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2008 | 207 | 0.080 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 111 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 1054 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 767 | 0.070 |
Why?
|
| Heart | 1 | 2012 | 850 | 0.070 |
Why?
|
| Rest | 1 | 2007 | 78 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 53 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 800 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 107 | 0.070 |
Why?
|
| Preventive Medicine | 1 | 2006 | 48 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 567 | 0.070 |
Why?
|
| Depression | 1 | 2012 | 943 | 0.060 |
Why?
|
| Iowa | 2 | 2015 | 33 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 306 | 0.060 |
Why?
|
| Maillard Reaction | 1 | 2023 | 7 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2007 | 1738 | 0.050 |
Why?
|
| Self Report | 2 | 2016 | 371 | 0.050 |
Why?
|
| Obesity, Abdominal | 1 | 2022 | 5 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2016 | 307 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.050 |
Why?
|
| Food | 1 | 2023 | 52 | 0.050 |
Why?
|
| Receptors, Progesterone | 2 | 2014 | 57 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 4 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2014 | 737 | 0.050 |
Why?
|
| Effect Modifier, Epidemiologic | 2 | 2014 | 8 | 0.050 |
Why?
|
| Health Surveys | 2 | 2016 | 489 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2015 | 330 | 0.050 |
Why?
|
| Pregnancy | 2 | 2017 | 2334 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 153 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 319 | 0.040 |
Why?
|
| Health Education | 1 | 2022 | 279 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2019 | 32 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 301 | 0.040 |
Why?
|
| Family Nurse Practitioners | 1 | 2018 | 2 | 0.040 |
Why?
|
| Iran | 1 | 2018 | 12 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 34 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 18 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2018 | 42 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 46 | 0.040 |
Why?
|
| Argentina | 1 | 2017 | 9 | 0.040 |
Why?
|
| Comprehension | 1 | 2018 | 71 | 0.040 |
Why?
|
| Jordan | 1 | 2017 | 4 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 225 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 618 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2017 | 51 | 0.040 |
Why?
|
| Poultry | 1 | 2017 | 14 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 1213 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2018 | 113 | 0.040 |
Why?
|
| Beta-Cryptoxanthin | 1 | 2016 | 1 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 128 | 0.030 |
Why?
|
| Anthropometry | 1 | 2016 | 64 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 261 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2015 | 4 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 2015 | 13 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 45 | 0.030 |
Why?
|
| MEDLINE | 1 | 2015 | 9 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 38 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 84 | 0.030 |
Why?
|
| Weight Gain | 1 | 2016 | 135 | 0.030 |
Why?
|
| Anthocyanins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2015 | 22 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 27 | 0.030 |
Why?
|
| Metaplasia | 1 | 2015 | 27 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 36 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 196 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 180 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2015 | 27 | 0.030 |
Why?
|
| Natural Gas | 1 | 2014 | 1 | 0.030 |
Why?
|
| Health Personnel | 1 | 2018 | 286 | 0.030 |
Why?
|
| Coal | 1 | 2014 | 2 | 0.030 |
Why?
|
| Wood | 1 | 2014 | 5 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 386 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 672 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2014 | 19 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 947 | 0.030 |
Why?
|
| Hospital Records | 1 | 2014 | 3 | 0.030 |
Why?
|
| Birth Certificates | 1 | 2014 | 16 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 109 | 0.030 |
Why?
|
| Skin Tests | 1 | 2014 | 30 | 0.030 |
Why?
|
| Mindfulness | 1 | 2015 | 41 | 0.030 |
Why?
|
| Mortality | 1 | 2015 | 163 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 19 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 103 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 70 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 119 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2014 | 33 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2014 | 13 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 381 | 0.030 |
Why?
|
| India | 1 | 2014 | 41 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 174 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 144 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2014 | 68 | 0.030 |
Why?
|
| Massachusetts | 1 | 2013 | 28 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2013 | 31 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 73 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 95 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2014 | 220 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2014 | 156 | 0.030 |
Why?
|
| Saliva | 1 | 2014 | 142 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 7029 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2015 | 183 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2013 | 5 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2018 | 703 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 271 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 123 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 546 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 26 | 0.020 |
Why?
|
| Mentors | 1 | 2012 | 81 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 121 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 14 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2455 | 0.020 |
Why?
|
| Endoscopy | 1 | 2014 | 464 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 116 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 115 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 188 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 219 | 0.020 |
Why?
|
| Minority Groups | 1 | 2012 | 197 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1451 | 0.020 |
Why?
|
| Mental Health | 1 | 2012 | 278 | 0.020 |
Why?
|
| Search Engine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Goals | 1 | 2010 | 65 | 0.020 |
Why?
|
| Heart Rate | 1 | 2012 | 568 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2009 | 69 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2009 | 86 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2009 | 15 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 159 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2010 | 199 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 442 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 144 | 0.020 |
Why?
|
| Seasons | 1 | 2009 | 129 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 579 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2009 | 392 | 0.020 |
Why?
|
| Progesterone | 1 | 2009 | 115 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 291 | 0.020 |
Why?
|
| Students | 1 | 2010 | 233 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 2891 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 508 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3187 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1196 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1664 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 756 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 292 | 0.020 |
Why?
|
| Flavanones | 1 | 2006 | 6 | 0.020 |
Why?
|
| Flavonols | 1 | 2006 | 2 | 0.020 |
Why?
|
| Food Analysis | 1 | 2006 | 10 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1753 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 2791 | 0.020 |
Why?
|
| Mass Screening | 1 | 2006 | 843 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 8474 | 0.010 |
Why?
|